Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2008 (Vol. 28, No. 7)

The GDB Human Genome Database

  • Mass of info with easy access
  • Broken links
The GDB Human Genome Database is, as its name says, a database of the human genome, an honor that is shared by only a few thousand or so other sites. What distinguishes this one, at least by its title, is that it is the “Official World-Wide Database for the Annotation of the Human Genome.” I wasn’t aware that such official databases exist, but this one apparently does. Flippancy aside, an annotated human genome is important for everyone, and having a single site responsible for this is a good idea. The opening page contains a powerful search engine that allows searches by many criteria including name, ID, and citation. Advanced search options are also available. If one clicks on the section entitled “HUGO Chromosomes,” one will discover a section of the site with many broken links, at least if one clicks on a chromosome number followed by clicking on Gene/Transcript Maps. That’s a relatively small complaint, though the problem extended across every chromosome I checked. Overall, the beauty of the GDB database is that it makes access to human gene info easy.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »